AGE Reader

Recente publicaties

Please find below an overview of all recent publications about the AGE Reader:

• • Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow up. Blanc-Bisson C. et al. Cardiovascular Diabetology. 2018 June 8; 17:82. doi: 10.1186/s12933-018-0718-8.
  • Association between Self-reported Physical Activity and Skin Autofluorescence, a market of Tissue Accumulation of Advanced Glycation End Products in Adults with Type 1 Diabetes: A Cross-sectional study. Duda-Sobczac A. et al. Clinical Therapeutics. 2018 June;40(6):872-880. doi: 10.1016/j.clinthera.2018.02.016. Epub 2018 Mar 19.
  • Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is not related to the number of pregnancies. van Waateringe R.P. et al. Journal of Diabetes; 2018 May 17; doi: 10.1111/1753-0407.12782.
  • Advanced Glycation End-products are associated with Physical Activity and Physical Functioning in the older population. Drenth H. et al. J. Gerontol A Biol Sci Med Scie. 2018 April 28. doi: 10.1093/gerona/gly108
  • Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project. Sanchez E. et al. Diabetes & Metabolism. 2018 April 13. doi: 10.1016/j.diabet.2018.04.002.
  • Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular disease. Fujino Y.  et al. Atherosclerosis. 2018 March 2. doi: 10.1016/j.atherosclerosis.2018.03.001
  • Advanced glycation end products in the pathogenesis of chronic kidney disease. Rabbani N. et al. Kidney International. 2018 February 22. doi: 10.1016/j.kint.2017
  • Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients With and Without Diabetes. Hu H. et al. 2018 Jan 10. doi: 10.1016/j.jcjd.2018.01.003 
  • Autofluorescence of Skin Advanced Glycation End Products as a Risk Factor for Open Angle Glaucoma: The ALIENOR Study. Schweitzer C. et al. Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):75-84.
  • Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population. Isami  et al. J Int Med Res. 2018 Jan 1:300060517736914. doi:10.1177/0300060517736914.
  • Skin accumulation of advanced glycation end products is increased in patients with an abdominal aortic aneurysm. Boersema J et al. J Vasc Surg. 2017 Dec;66(6):1696-1703.e1. doi: 10.1016/j.jvs.2017.04.037.
  • Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima-Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional Study. Yoshioka K. Diabetes Ther. 2017 Nov 24. doi: 10.1007/s13300-017-0339-3.
  • Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study. Niihata K. et al. J Am Med Dir Assoc. 2017 Nov 1. pii: S1525-8610(17)30520-0. doi: 10.1016/j.jamda.2017.09.008.
  • Skin autofluorescence improves the Finnish Diabetes Risk Score in the detection of diabetes in a large population-based cohort: The LifeLines Cohort Study. Fokkens B.T. et al. Diabetes Metab. 2017 Oct 30. pii: S1262-3636(17)30513-X. doi: 10.1016/j.diabet.2017.09.002.
  • Accumulation of advanced glycation end products evaluated by skin autofluorescence and incident frailty in older adults from the Bordeaux Three-City cohort. Pilleron S. et al. PLoS One. 2017 Oct 17;12(10):e0186087.
  • Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes. Rajaobelina K et al. Diabetes Metab Res Rev. 2017 Oct;33(7). doi: 10.1002/dmrr.2917.
  • Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus. Ahmad M.S. et al. PLoS One. 2017 Sep 20;12(9):e0185175.
  • Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder. França R.A. et al. J Bras Nefrol. 2017 Jul-Sep;39(3):253-260.
  • Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study. Botros N. et al. Diabetes Metab Res Rev. 2017 Jul;33(5).
  • Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults. Kellow N.J. et al. Eur J Nutr. 2017 Jun 27. doi: 10.1007/s00394-017-1495-y.
  • The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation. van Waateringe R.P. et al. PLoS One. 2017 Jun 20;12(6):e0179330
  • Re: Skin Autofluorescence (a Marker for Advanced Glycation End Products) and Erectile Dysfunction in Diabetes. Seftel A.D. et al. J Urol. 2017 Jun;197(6):1533-1535.
  • The relationship between circulating irisin levels and tissues AGE accumulation in type 2 diabetes patients. Li Z. et al. Biosci Rep. 2017 Jun 8;37(3).
  • Skin autofluorescence is associated with arterial stiffness and insulin level in endurance runners and healthy controls – Effects of aging and endurance exercise. Couppé C. et al. Exp Gerontol. 2017 May;91:9-14.
  • Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes. Mori H. et al. J Diabetes Investig. 2017 May;8(3):377-382.
  • Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations. Da Moura Semedo C. et al. Postgrad Med J. 2017 May;93(1099):289-294.
  • Relationship between advanced glycation end-product accumulation and low skeletal muscle mass in Japanese men and women. Kato M. et al. Geriatr Gerontol Int. 2017 May;17(5):785-790. 
  • Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components. van Waateringe R.P. et al.  Diabetol Metab Syndr. 2017 May 30;9:42.
  • Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk. Hagen J.M. et al. J Clin Psychiatry. 2017 Apr 25. doi: 10.4088/JCP.16m10972.
  • Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications. Cho Y.H. et al. Diabet Med. 2017 Apr;34(4):543-550.
  • Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study – protocol for a multicentre cross-sectional study. de Vos L.C. et al. BMJ Open. 2017 Apr 11;7(4):e012584.
  • Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls. Fokkens B.T. et al. PLoS One. 2017 Mar 6;12(3):e0173379.

For a complete overview of all publications please download our full publication list:

Publication list